When confronted with acute neurological symptoms such as headache, seizures, and visual disturbances in a cancer patient on anti-VEGF therapy, it is vital to exclude other potential causes before attributing findings to PRES. The gene discussed is VEGFA; the disease is Posterior Leukoencephalopathy Syndrome.